Lv2
108 积分 2025-03-11 加入
Investigating Barriers to Systemic Janus Kinase Inhibitor Access for Alopecia Areata
4小时前
求助中
Switching between Janus kinase inhibitors for treatment of alopecia areata: A multicenter retrospective review
4小时前
已完结
Efficacy and safety of deuruxolitinib, an oral selective Janus kinase 1/2 inhibitor, in adults with alopecia areata: Results from the THRIVE-AA2 Phase 3, randomized, double-blind, controlled trial
4小时前
已完结
Context, not class, may be the key signal in systemic JAK inhibitor exposure in MF/SS
5小时前
待确认
Ivarmacitinib ointment in treatment of adults with mild-to-moderate atopic dermatitis: phase III of a randomized double-blind placebo-controlled phase II/III clinical trial
5小时前
已完结
Pediatric JAK Inhibitor Use and Height in Common Inflammatory Diseases
6小时前
已完结
Pediatric JAK Inhibitor Use and Height in Common Inflammatory Diseases
6小时前
已完结
Real-world outcomes of 24-week abrocitinib tapering in moderate-to-severe atopic dermatitis: Feasibility and regimen comparison
18小时前
已完结
Vitiligo is associated with lower body mass index: a retrospective case-control study
11个月前
已完结
皖公网安备34019202002308
